Randomised Control Trials
The Western Vascular Institute, along with 25 other European centres are involved in a post market surveillance, multi-centre EU clinical trial of the Cordis INCRAFT® abdominal aortic aneurysm (AAA) Stent-Graft System.
The aim of the trial is to evaluate the safety and effectiveness of INCRAFT device in patients with AAAs. Approximately 150 patients have been enrolled and will be followed over 5 years.
For more information click on clinicaltrials.gov
Clinical trial identifier: NCT02477111
About the MFM Global Registry
The Cardiatis Multilayer Flow Modulator is a disruptive technology. It is an innovative Stent which represents a new concept in the management of Aortic disease. The mode of action of this device is completely different from that of conventional aortic devices, which has caused much scepticism among the vascular community worldwide. However, positive clinical outcomes have forced a more thorough investigation of this new device and the team at the Western Vascular Institute have been commissioned to undertake this exploratory task.
The Western Vascular Institute is heading an independent registry, Multilayer Flow Modulator® Global Registry to collect data from the surgeons and interventionalists around the world who have used this stent to treat thoracoabdominal aortic pathologies. The experienced team at the Western Vascular Institute will objectively analyse the clinical outcomes in patients treated with this stent as well as engaging in independent biomedical testing of the device.
For more information click on MFMGR
Jotec SECURE Regsitry
Medtronic ENCHANT Trial
Images property of J&J, and Cardiatis.